Patents matching “modified”

US 6762286

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Jul 13, 2004 · Expires Jul 8, 2024

US 6747003

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Jun 8, 2004 · Expires Jun 3, 2024

US 6693075

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Feb 17, 2004 · Expires Feb 12, 2024

US 6692910

Inhibition of a target messenger RNA with a modified U1 small nuclear RNA

UNIVERSITY OF CONNECTICUT · Granted Feb 17, 2004 · Expires Feb 12, 2024

US 6685944

Modified HCV peptide vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Feb 3, 2004 · Expires Jan 29, 2024

US 6680291

Modified ciliary neurotrophic factor, method of making and methods of use thereof

REGENERON PHARMACEUTICALS, INC. · Granted Jan 20, 2004 · Expires Jan 15, 2024

US 6642363

Polymers containing polysaccharides such as alginates or modified alginates

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 4, 2003 · Expires Oct 30, 2023

US 6620927

Thiol-modified hyaluronan

ANIKA THERAPEUTICS, INC. · Granted Sep 16, 2003 · Expires Sep 11, 2023

US 6600012

Lipid-modified muc-1 derivatives

Biomira, Inc. · Granted Jul 29, 2003 · Expires Jul 24, 2023

US 6566326

Chemically modified hemoglobin for burn shock resuscitation

The Regents of the University of California · Granted May 20, 2003 · Expires May 15, 2023

US 6521417

Engineered protein kinases which can utilize modified nucleotide triphosphate substrates

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Feb 18, 2003 · Expires Feb 13, 2023

US 6500640

Nucleic acid molecules encoding modified dorsal tissue affecting factor

The Regents of the University of California · Granted Dec 31, 2002 · Expires Dec 26, 2022

US 6472178

Nucleic acids encoding a modified ciliary neurotrophic factor and method of making thereof

REGENERON PHARMACEUTICALS, INC. · Granted Oct 29, 2002 · Expires Oct 24, 2022

US 2002127247

Modified clostridial neurotoxins with altered biological persistence

ALLERGEN SALES INC [US] · Granted Sep 12, 2002 · Expires Sep 7, 2022

US 6440702

Nucleic acids encoding modified ciliary neurotrophic factors

REGENERON PHARMACEUTICALS, INC. · Granted Aug 27, 2002 · Expires Aug 22, 2022

US 6410510

Administration modified ciliary neurotrophic factors

REGENERON PHARMACEUTICALS, INC. · Granted Jun 25, 2002 · Expires Jun 20, 2022

US 6390821

Engineered protein kinases which can utilize modified nucleotide triphosphate substrates

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted May 21, 2002 · Expires May 16, 2022

US 6284536

Modified immunoglobin molecules and methods for use thereof

The Regents of the University of California · Granted Sep 4, 2001 · Expires Aug 30, 2021

US 6165781

Modified adeno-associated virus vector capable of expression from a novel promoter

The United States of America, as represented by the Department of Health and Human Services · Granted Dec 26, 2000 · Expires Dec 21, 2020

US 6096727

Method for treating wounds using modified hyaluronic acid crosslinked with biscarbodiimide

ANIKA THERAPEUTICS, INC. · Granted Aug 1, 2000 · Expires Jul 27, 2020

US 6075007

Modified noggin polypeptide and compositions

THE REGENTS OF THE UNIV. OF CALIFORNIA · Granted Jun 13, 2000 · Expires Jun 8, 2020

US 6072072

Compounds for preparing modified hemoglobin

Montefiore Medical Center · Granted Jun 6, 2000 · Expires Jun 1, 2020

US 6060505

Method of treating cancer using C-26 modified bryostatin

The United States of America, as represented by the Department of Health and Human Services · Granted May 9, 2000 · Expires May 4, 2020

US 6019981

Modified live Edwardsiella ictaluri against enteric septicemia in channel catfish

The United States of America, as represented by the Secretary of Agriculture · Granted Feb 1, 2000 · Expires Jan 27, 2020